LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 73 filers reported holding LOXO ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $14,226,000 | -8.6% | 169,000 | 0.0% | 0.56% | -20.1% |
| Q3 2017 | $15,568,000 | -22.7% | 169,000 | -32.7% | 0.70% | -34.7% |
| Q2 2017 | $20,141,000 | -36.5% | 251,167 | -66.7% | 1.07% | -12.2% |
| Q1 2017 | $31,699,000 | +293.2% | 753,300 | +200.1% | 1.22% | +268.4% |
| Q4 2016 | $8,061,000 | +22.7% | 251,000 | 0.0% | 0.33% | +8.5% |
| Q3 2016 | $6,571,000 | +12.9% | 251,000 | 0.0% | 0.31% | +33.6% |
| Q2 2016 | $5,818,000 | -15.2% | 251,000 | 0.0% | 0.23% | -21.6% |
| Q1 2016 | $6,862,000 | -3.9% | 251,000 | 0.0% | 0.29% | +1.0% |
| Q4 2015 | $7,141,000 | -62.5% | 251,000 | -76.9% | 0.29% | -60.7% |
| Q3 2015 | $19,022,000 | -27.2% | 1,088,225 | -25.0% | 0.74% | -15.5% |
| Q2 2015 | $26,146,000 | +32.0% | 1,450,151 | -8.9% | 0.87% | +35.7% |
| Q1 2015 | $19,815,000 | +6.0% | 1,591,546 | 0.0% | 0.64% | -4.5% |
| Q4 2014 | $18,701,000 | -10.5% | 1,591,546 | 0.0% | 0.67% | -11.8% |
| Q3 2014 | $20,897,000 | – | 1,591,546 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
| DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
| Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
| Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
| SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
| AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
| Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
| Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
| Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |